1,094
Views
20
CrossRef citations to date
0
Altmetric
Letters to the Editor

NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 3222-3226 | Received 16 Dec 2014, Accepted 02 Mar 2015, Published online: 12 May 2015
 

Potential conflict of interest

CM and BF applied for a patent on the clinical use of NPM1 mutants. The other authors report no potential conflicts of interest. Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal

Funding

This work was supported by grants from the Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL) Sezione ‘Luciano Pavarotti’ Modena-ONLUS and from the Associazione Italiana per la Ricerca sul Cancro [AIRC, IG 14797-2013].

Supplementary material available online

Molecular and immunohistochemical examinations including Supplementary Tables I and II.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.